Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases. - Hamilton, Jennifer D.; Harel, Sivan; Swanson, Brian N.; Brian, William; Chen, Zhen; Rice, Megan S.; Amin, Nikhil; Ardeleanu, Marius; Radin, Allen; Shumel, Brad; Ruddy, Marcella; Patel, Naimish; et al. (Clinical & Experimental Allergy, 2021)